William D. Lubell, Ph.D., studies medicinal chemistry and peptide science through the innovation of peptides and peptidomimetics that target and modulate biologically relevant receptors for drug discovery. Co-author of >250 scientific publications, former Associate Editor of Organic Letters (2005-2018), editorial board member of journals in the biomedical sciences, and innovator of intellectual property used to launch start-up companies, Lubell received the 2013 Canadian Society for Chemistry Bernard Belleau and the 2018 Teva Canada Limited Biological and Medicinal Chemistry Lectureship Awards. Forging collaborations with biochemists, pharmacologists, and physicians, his efforts are critical in drug discovery teams developing interventions to treat Alzheimer’s disease, premature birth, an unmet medical need with the highest cost per patient, and age-related macular degeneration, the leading cause of adult blindness. The originator of Molecules of Life (www.moleculesoflife.ca) and co-author of the Molecular Marvels of Superheroes Series, Lubell explores experiential education techniques to teach the public about science.

Learn more by visiting the Lubell lab page, Dr. Lubell’s Université de Montréal directory page, or his biography page.